Results 91 to 100 of about 9,558 (217)

Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012) [PDF]

, 2016
OBJECTIVES: To evaluate the prevalence of transmitted drug resistance (TDR) and non-B subtypes in patients with acute/recent HIV-1 infection in Barcelona during the period 1997-2012.
Agüero Santangelo, Fernando, Ambrosioni, Juan, Gatell, José M., Gómez-Carrillo, Manuel, López-Diéguez, María, Manzardo, Christian, Marcos, Ma. Angeles, Miró Meda, José M., Nicolás, David, Parera, Marta, Pumarola Suñé, Tomás, Romero, Anabel, Sued, Omar, Zamora, Laura   +13 more
core   +1 more source

The Meandrous Route of Rilpivirine in the Search for the Miraculous Drug to Treat HIV Infections

Viruses
Rilpivirine (RPV, R278474) was highlighted in 2005, two years after the death of Dr. Paul Janssen, as the ideal non-nucleoside reverse transcriptase inhibitor (NNRTI) to treat HIV infections.
Erik De Clercq
doaj   +1 more source

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study [PDF]

, 2017
Background Surveillance of HIV-1 drug resistance in treated patients with plasma viral load (VL) >50 copies/mL. Methods The protease and reverse transcriptase (RT) genes were systematically sequenced in samples from 756 patients with VL >50 copies/mL in ...
Assoumou, Lambert, Chaix, Marie-Laure, Costagliola, Dominique, Delaugerre, Constance, Descamps, Diane, Dos Santos, Georges, Izopet, Jacques, Marcelin, Anne-Geneviève, Masquelier, Bernard, Montes, Brigitte, Morand-Joubert, Laurence, Pakianather, Sophie, Plantier, Jean-Christophe, Ruffault, Annick, Wirden, Marc, Yerly, Sabine   +15 more
core  

Mapping networks of anti-HIV drug cocktails vs. AIDS epidemiology in the US counties [PDF]

, 2014
[Abstract] The implementation of the highly active antiretroviral therapy (HAART) and the combination of anti-HIV drugs have resulted in longer survival and a better quality of life for the people infected with the virus.
González-Díaz, Humberto, Herrera-Ibatá, Diana María, Orbegozo-Medina, Ricardo Alfredo, Pazos, A.   +3 more
core   +2 more sources

Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV: Data from the Veterans Aging Cohort Study [PDF]

, 2019
Background: Insomnia is associated with increased cardiovascular disease (CVD) risk in the general population and is highly prevalent in people with HIV. The CVD risk conferred by insomnia in the HIV population is unknown.
Bedimo, Roger J., Budoff, Matthew J., Butt, Adeel A., Chang, Chung-Chou H., Freiberg, Matthew S., Gottlieb, Stephen S., Gupta, Samir K., Kundu, Suman, Marconi, Vincent C., Polanka, Brittanny M., So-Armah, Kaku A., Stewart, Jesse C., Womack, Julie A.   +12 more
core   +1 more source

Cardiovascular risk and dyslipidemia among persons living with HIV: A review [PDF]

, 2017
Background: Aim of this review is to focus the attention on people living with HIV infection at risk of developing a cardiovascular event. What is or what would be the most suitable antiretroviral therapy Which statin or fibrate to reduce the risk How to
Cicalini, S, D'Abbraccio, M, d'Ettorre, G, Di Biagio, A, Maggi, P, Martinelli, C, Nunnari, G, Rusconi, S, Sighinolfi, L, Spagnuolo, V, Squillace, N   +10 more
core   +3 more sources

Transmitted drug resistance to rilpivirine among antiretroviral‐naïve patients living with HIV from northern Poland

Journal of the International AIDS Society, 2014
Introduction Rilpivirine (RPV) is a second‐generation non‐nucleoside reverse transcriptase inhibitor (NNRTI) that was recently approved for the treatment of antiretroviral‐naïve individuals with HIV‐1 viral load of
Miłosz Parczewski, Anna Urbańska, Katarzyna Maciejewska, Magdalena Witak‐Jȩdra, Magdalena Leszczyszyn‐Pynka   +4 more
doaj   +1 more source

Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals. [PDF]

, 2015
BackgroundClinically significant dysregulation of the insulin-like growth factor (IGF) family proteins occurs in HIV-infected individuals, but the details including whether the deficiencies in IGFs contribute to CNS dysfunction are unknown.MethodsWe ...
Choi, Namjong, Lee, Sunhee C, Letendre, Scott, Lo, Yungtai, Suh, Hyeon-Sook   +4 more
core   +2 more sources

Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow, Amanda Binkley, Jessica Meisner, Samantha Huo, Matthew Hinton   +4 more
wiley   +1 more source

Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV

Frontiers in Pharmacology
BackgroundThe pharmacokinetics of long-acting rilpivirine has mostly been studied in clinical trials, which do not fully address the uncertainties that arise in routine clinical situations.Aims and methodsOur population analysis aims to establish ...
Paul Thoueille, Paul Thoueille, Susana Alves Saldanha, Fabian Schaller, Eva Choong, François Veuve, Aline Munting, Matthias Cavassini, Dominique Braun, Dominique Braun, Huldrych F. Günthard, Huldrych F. Günthard, Jessy J. Duran Ramirez, Jessy J. Duran Ramirez, Bernard Surial, Hansjakob Furrer, Andri Rauch, Pilar Ustero, Alexandra Calmy, Alexandra Calmy, Marcel Stöckle, Caroline Di Benedetto, Enos Bernasconi, Patrick Schmid, Catia Marzolini, Catia Marzolini, Catia Marzolini, François R. Girardin, François R. Girardin, Thierry Buclin, Laurent A. Decosterd, Monia Guidi, Monia Guidi, Monia Guidi   +33 more
doaj   +1 more source